<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02365298</url>
  </required_header>
  <id_info>
    <org_study_id>CR-5695</org_study_id>
    <nct_id>NCT02365298</nct_id>
  </id_info>
  <brief_title>Clinical and Laboratory Study of Lysozyme Deposition on Daily Disposable Contact Lenses</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In vitro studies show that some hydrogel materials uptake more lysozyme than other hydrogel
      materials and that this protein remains largely active and promotes reduced cytokine response
      in an in vitro culture of human corneal epithelial cells. This study investigates whether
      these data transfer to the in vivo situation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Actual">June 1, 2015</completion_date>
  <primary_completion_date type="Actual">June 1, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Protein and Total Lysosome Deposits</measure>
    <time_frame>2 wks after baseline</time_frame>
    <description>Measurement will be taken after the subject has worn the lenses for a full seven hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Protein and Total Lysosome Deposits</measure>
    <time_frame>6 wks after baseline</time_frame>
    <description>Measurement will be taken after the subject has worn the lenses for a full seven hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Protein and Lysosome Deposits</measure>
    <time_frame>12 wks after baseline</time_frame>
    <description>Measurement will be taken after the subject has worn the lenses for a full seven hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantity of Cytokines and Albumin in Tear Fluid</measure>
    <time_frame>2 wks after baseline</time_frame>
    <description>Measured cytokines: IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12, IL-13, and TNF-alpha Measurement will be taken after the subject has worn the lenses for a full seven hours.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantity of Cytokines and Albumin in Tear Fluid</measure>
    <time_frame>6 wks after baseline</time_frame>
    <description>Measured cytokines: IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12, IL-13, and TNF-alpha. Measurement will be taken after the subject has worn the lenses for a full seven hours. During the 2nd period subjects continued wearing the current lens that they were randomized to for an additional 6 weeks of wear.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantity of Cytokines and Albumin in Tear Fluid</measure>
    <time_frame>12 wks after baseline</time_frame>
    <description>Measured cytokines: IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12, IL-13, and TNF-alpha. Measurement will be taken after the subject has worn the lenses for a full seven hours. During the 2nd period subjects continued wearing the current lens that they were randomized to for an additional 6 weeks of wear.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Visual Acuity</condition>
  <arm_group>
    <arm_group_label>etafilcon A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Worn in a daily disposable modality</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nelfilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Worn in a daily disposable modality</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>etafilcon A</intervention_name>
    <description>etafilcon A soft contact lens</description>
    <arm_group_label>etafilcon A</arm_group_label>
    <arm_group_label>nelfilcon A</arm_group_label>
    <other_name>Marketed Investigational Soft Contact Lens</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nelfilcon A</intervention_name>
    <description>nelfilcon A</description>
    <arm_group_label>etafilcon A</arm_group_label>
    <arm_group_label>nelfilcon A</arm_group_label>
    <other_name>Marketed Investigational Soft Contact Lens</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject must read, understand, and sign the Statement of Informed Consent and
             receive a fully executed copy of the form.

          2. The subject must appear able and willing to adhere to the instructions set forth in
             the clinical protocol.

          3. The subject must be willing to follow instructions and maintain the appointment
             schedule.

          4. The subject must be between 18 and 40 years of age (inclusive).

          5. The subject's vertex corrected spherical equivalent distance refraction must be in the
             range of -0.50D to -6.00D in each eye (inclusive).

          6. The subject's refractive cylinder must not exceed -1.25DC in each eye after vertexing
             to the corneal plane.

          7. The subject must be a current wearer of spherical, soft contact lenses (no toric,
             bifocal or multifocal contact lenses, no extended wear or monovision) for at least 5
             days/week and at least 8 hours/day during to month prior to enrollment.

          8. The subject must own a wearable pair of spectacles and wear them the day of the
             initial visit.

          9. The subject must be an existing wearer of spherical soft contact lenses in both eyes.

         10. The subject must have normal eye (i.e., no ocular medications or infections of any
             type).

         11. The subject must be able to wear the study lenses for a minimum seven hours per day.

        Exclusion Criteria:

          1. Any ocular or systemic allergies or diseases that may interfere with contact lens wear
             (at the investigator's discretion).

          2. Any systemic disease, autoimmune disease, or use of medication, which may interfere
             with contact lens wear (at the investigator's discretion).

          3. Currently pregnant or lactating (subjects who become pregnant during the study will be
             discontinued).

          4. Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious
             immunosuppressive disease.

          5. Any active ocular infection.

          6. Is using any topical medication including artificial tears (ATS) up to two weeks prior
             to the screening visit.

          7. Any participants whose habitual contact lenses are used as an extended wear regimen.

          8. Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of
             recurrent corneal erosions, aphakia, or moderate or above corneal distortion by
             keratometry.

          9. Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal
             staining, or any other abnormalities of the cornea which would contraindicate contact
             lens wear; clinically significant (grade 3 or 4) tarsal abnormalities or bulbar
             injection which might interfere with contact lens wear.

         10. Any know hypersensitivity or allergic reaction to study products.

         11. Participation in any contact lens or lens care product clinical trial within seven
             days prior to study enrollment.

         12. Employee or family member of the Center for Contact Lens Research (e.g., Investigator,
             Coordinator, Technician).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Waterloo</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2015</study_first_submitted>
  <study_first_submitted_qc>February 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2015</study_first_posted>
  <results_first_submitted>June 12, 2017</results_first_submitted>
  <results_first_submitted_qc>June 12, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 13, 2017</results_first_posted>
  <last_update_submitted>April 6, 2018</last_update_submitted>
  <last_update_submitted_qc>April 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Etafilcon a /Nelfilcon A</title>
          <description>Subjects that were randomized to receive the etafilcon A lens first, and then to receive the nelfilcon A lens second.</description>
        </group>
        <group group_id="P2">
          <title>Nelfilcon A / Etafilcon A</title>
          <description>Subjects that were randomized to receive the nelfilcon A lens first, and then to receive the etafilcon A lens second.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Period 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>incorrect Rx dispensed</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discontinued at request of Sponsor</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Test Article longer available</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All subjects dispensed at least one study lens during the duration of the study.</population>
      <group_list>
        <group group_id="B1">
          <title>All Dispensed Subjects</title>
          <description>All subjects that were dispensed a study lens.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.3" spread="4.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Protein and Total Lysosome Deposits</title>
        <description>Measurement will be taken after the subject has worn the lenses for a full seven hours</description>
        <time_frame>2 wks after baseline</time_frame>
        <population>All subjects that completed all study visits without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon A</title>
            <description>Subjects that wore the etafilcon A lens in either the first or second period of the study.</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>Subjects that wore the nelfilcon A lens in either the first or second period of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Protein and Total Lysosome Deposits</title>
          <description>Measurement will be taken after the subject has worn the lenses for a full seven hours</description>
          <population>All subjects that completed all study visits without a major protocol deviation.</population>
          <units>(ug/lens)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Total Lysozyme</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="294.58" spread="113.855"/>
                    <measurement group_id="O2" value="1.68" spread="0.975"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Active Lysozyme</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="244.00" spread="87.325"/>
                    <measurement group_id="O2" value="0.93" spread="0.650"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total Proteins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="482.06" spread="139.196"/>
                    <measurement group_id="O2" value="6.46" spread="3.953"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Protein and Total Lysosome Deposits</title>
        <description>Measurement will be taken after the subject has worn the lenses for a full seven hours</description>
        <time_frame>6 wks after baseline</time_frame>
        <population>Subjects that completed all study visits without a major protocol deviation. During the 2nd period subjects continued wearing the current lens that they were randomized to for an additional 6 weeks of wear.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon A</title>
            <description>Subjects that wore the etafilcon A lens in either the first or second period of the study.</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>Subjects that wore the nelfilcon A lens in either the first or second period of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Protein and Total Lysosome Deposits</title>
          <description>Measurement will be taken after the subject has worn the lenses for a full seven hours</description>
          <population>Subjects that completed all study visits without a major protocol deviation. During the 2nd period subjects continued wearing the current lens that they were randomized to for an additional 6 weeks of wear.</population>
          <units>(ug/lens)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Total Lysozyme</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="349.00" spread="58.845"/>
                    <measurement group_id="O2" value="2.26" spread="1.460"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Active Lysozyme</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="263.92" spread="38.562"/>
                    <measurement group_id="O2" value="1.13" spread="0.538"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total Proteins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="473.58" spread="131.432"/>
                    <measurement group_id="O2" value="7.46" spread="4.151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Protein and Lysosome Deposits</title>
        <description>Measurement will be taken after the subject has worn the lenses for a full seven hours</description>
        <time_frame>12 wks after baseline</time_frame>
        <population>All subjects that completed all study visits without a major protocol deviation.During the 2nd period subjects continued wearing the current lens that they were randomized to for an additional 6 weeks of wear.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon A</title>
            <description>Subjects that wore the etafilcon A lens in either the first or second period of the study.</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>Subjects that wore the nelfilcon A lens in either the first or second period of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Protein and Lysosome Deposits</title>
          <description>Measurement will be taken after the subject has worn the lenses for a full seven hours</description>
          <population>All subjects that completed all study visits without a major protocol deviation.During the 2nd period subjects continued wearing the current lens that they were randomized to for an additional 6 weeks of wear.</population>
          <units>(ug/lens)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Total Lysozyme</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="289.17" spread="78.838"/>
                    <measurement group_id="O2" value="1.58" spread="0.851"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Active Lysozymes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="242.75" spread="57.974"/>
                    <measurement group_id="O2" value="1.01" spread="0.567"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total Proteins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="394.42" spread="122.302"/>
                    <measurement group_id="O2" value="5.87" spread="3.181"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Quantity of Cytokines and Albumin in Tear Fluid</title>
        <description>Measured cytokines: IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12, IL-13, and TNF-alpha Measurement will be taken after the subject has worn the lenses for a full seven hours.</description>
        <time_frame>2 wks after baseline</time_frame>
        <population>Subjects that completed all study visits without a major protocol deviation. All 24 subjects completed the study, however in some subjects the concentration of cytokine levels were below detectable limits in the tear film sample and could not be analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon A</title>
            <description>Subjects that wore the etafilcon A lens in either the first or second period of the study.</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>Subjects that wore the nelfilcon A lens in either the first or second period of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Quantity of Cytokines and Albumin in Tear Fluid</title>
          <description>Measured cytokines: IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12, IL-13, and TNF-alpha Measurement will be taken after the subject has worn the lenses for a full seven hours.</description>
          <population>Subjects that completed all study visits without a major protocol deviation. All 24 subjects completed the study, however in some subjects the concentration of cytokine levels were below detectable limits in the tear film sample and could not be analyzed.</population>
          <units>(pg/ml)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>TFN-a</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.20" spread="0.528"/>
                    <measurement group_id="O2" value="1.17" spread="1.095"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-1B</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.70" spread="1.810"/>
                    <measurement group_id="O2" value="2.32" spread="3.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.19" spread="0.841"/>
                    <measurement group_id="O2" value="1.49" spread="1.770"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                    <count group_id="O2" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.32" spread="11.756"/>
                    <measurement group_id="O2" value="15.03" spread="18.835"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="23"/>
                    <count group_id="O2" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="466.32" spread="291.109"/>
                    <measurement group_id="O2" value="472.91" spread="273.444"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-10</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.02" spread="1.879"/>
                    <measurement group_id="O2" value="1.64" spread="1.389"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.72" spread="5.218"/>
                    <measurement group_id="O2" value="2.25" spread="2.685"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-13</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.62" spread="19.510"/>
                    <measurement group_id="O2" value="27.23" spread="23.651"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Quantity of Cytokines and Albumin in Tear Fluid</title>
        <description>Measured cytokines: IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12, IL-13, and TNF-alpha. Measurement will be taken after the subject has worn the lenses for a full seven hours. During the 2nd period subjects continued wearing the current lens that they were randomized to for an additional 6 weeks of wear.</description>
        <time_frame>6 wks after baseline</time_frame>
        <population>All subjects that completed all study visits without a major protocol deviation. All 12 subjects completed the study, however in some subjects the concentration of cytokine levels were below detectable limits in the tear film sample and could not be analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon A</title>
            <description>Subjects that wore the etafilcon A lens in either the first or second period of the study.</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>Subjects that wore the nelfilcon A lens in either the first or second period of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Quantity of Cytokines and Albumin in Tear Fluid</title>
          <description>Measured cytokines: IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12, IL-13, and TNF-alpha. Measurement will be taken after the subject has worn the lenses for a full seven hours. During the 2nd period subjects continued wearing the current lens that they were randomized to for an additional 6 weeks of wear.</description>
          <population>All subjects that completed all study visits without a major protocol deviation. All 12 subjects completed the study, however in some subjects the concentration of cytokine levels were below detectable limits in the tear film sample and could not be analyzed.</population>
          <units>(pg/ml)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>TNF-a</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.20" spread="1.111"/>
                    <measurement group_id="O2" value="0.49" spread="0.242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-1B</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.83" spread="1.595"/>
                    <measurement group_id="O2" value="4.99" spread="6.297"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.50" spread="1.528"/>
                    <measurement group_id="O2" value="1.06" spread="0.569"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.70" spread="11.281"/>
                    <measurement group_id="O2" value="11.91" spread="17.135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="480.99" spread="353.994"/>
                    <measurement group_id="O2" value="481.08" spread="346.982"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-10</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.90" spread="1.002"/>
                    <measurement group_id="O2" value="0.55" spread="0.341"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.42" spread="0.139"/>
                    <measurement group_id="O2" value="0.56" spread="0.222"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-13</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.78" spread="17.396"/>
                    <measurement group_id="O2" value="14.10" spread="8.998"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Quantity of Cytokines and Albumin in Tear Fluid</title>
        <description>Measured cytokines: IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12, IL-13, and TNF-alpha. Measurement will be taken after the subject has worn the lenses for a full seven hours. During the 2nd period subjects continued wearing the current lens that they were randomized to for an additional 6 weeks of wear.</description>
        <time_frame>12 wks after baseline</time_frame>
        <population>All subjects that completed all study visits without a major protocol deviation. All 12 subjects completed the study, however in some subjects the concentration of cytokine levels were below detectable limits in the tear film sample and could not be analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Etafilcon A</title>
            <description>Subjects that wore the etafilcon A lens in either the first or second period of the study.</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A</title>
            <description>Subjects that wore the nelfilcon A lens in either the first or second period of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Quantity of Cytokines and Albumin in Tear Fluid</title>
          <description>Measured cytokines: IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12, IL-13, and TNF-alpha. Measurement will be taken after the subject has worn the lenses for a full seven hours. During the 2nd period subjects continued wearing the current lens that they were randomized to for an additional 6 weeks of wear.</description>
          <population>All subjects that completed all study visits without a major protocol deviation. All 12 subjects completed the study, however in some subjects the concentration of cytokine levels were below detectable limits in the tear film sample and could not be analyzed.</population>
          <units>(pg/ml)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>TFN-a</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.57" spread="0.411"/>
                    <measurement group_id="O2" value="0.85" spread="0.772"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-1B</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                    <count group_id="O2" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.18" spread="6.079"/>
                    <measurement group_id="O2" value="8.14" spread="10.250"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.43" spread="1.314"/>
                    <measurement group_id="O2" value="1.09" spread="0.479"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.18" spread="6.155"/>
                    <measurement group_id="O2" value="21.33" spread="26.329"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                    <count group_id="O2" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="473.86" spread="164.445"/>
                    <measurement group_id="O2" value="879.82" spread="922.383"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-10</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" spread="1.060"/>
                    <measurement group_id="O2" value="1.17" spread="0.618"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.74" spread="0.211"/>
                    <measurement group_id="O2" value="0.51" spread="0.429"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-13</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.56" spread="5.053"/>
                    <measurement group_id="O2" value="29.91" spread="8.963"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Approximately 81-87 days per subject.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Etafilcon A</title>
          <description>Subjects that wore the etafilcon A lens in either the first or second period of the study.</description>
        </group>
        <group group_id="E2">
          <title>Nelfilcon A</title>
          <description>Subjects that wore the nelfilcon A lens in either the first or second period of the study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Common Cold</sub_title>
                <description>Not Study Related</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Chantal Coles-Brennan</name_or_title>
      <organization>Johnson &amp; Johnson Vision Care Inc.</organization>
      <phone>904-443-3449</phone>
      <email>CColesb@ITS.JNJ.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

